Becton Dickinson & Co.: Device Recall

Recall #Z-0026-2025 · 09/12/2024

Class II: Risk

Recall Details

Recall Number
Z-0026-2025
Classification
Class II
Product Type
Device
Recalling Firm
Becton Dickinson & Co.
Status
Ongoing
Date Initiated
09/12/2024
Location
Sparks, MD, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
162 units

Reason for Recall

Synapsys software versions 4.20, 4.30, 5.10, 5.20, or 5.30 and utilizing the in-line breakpoint feature, an error is occurring where BD Synapsys will incorrectly display breakpoints for organisms that do not have defined breakpoints in CLSI or EUCAST. This occurs when the identified organism is included in the same interpretive group as a species for which there is a specific breakpoint. May result in either a false susceptible or false resistant result. A false susceptible result can cause inadequate or incomplete antibiotic treatment due to the use of an ineffective antibiotic, and a false resistant result may limit access to a preferred antibiotic regimen with possible elongation of therapy

Product Description

BD Synapsys Informatics Solution with software versions: 4.20, 4.30, 5.10, 5.20 and 5.30- IVD standalone laboratory software solution providing data management and workflow management functionality across locations where clinical diagnostic activities take place. Catalog Number: 444150

Distribution Pattern

Nationwide Foreign: Australia, New Zealand, Singapore, Hong Kong, Taiwan, Japan, Austria, Belgium, Denmark, France, Germany, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom, Russia, Saudi Arabia, South Africa, Canada, Mexico, China

Other Recalls by Becton Dickinson & Co.

View all recalls by Becton Dickinson & Co. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.